Literature DB >> 21239028

Trends of mycobacterial clinical isolates in Taiwan.

Chin-Feng Tsai1, Ming-Yuh Shiau, Yih-Hsin Chang, Ya-Li Wang, Tian-Lin Huang, Yu-Ching Liaw, Shih-Ming Tsao, Tsi-Peng Yang, Shun-Chun Yang, Ding-Bang Lin.   

Abstract

Non-tuberculous mycobacteria (NTM) can cause chronic pulmonary infection, however, NTM infection is generally overlooked. This retrospective study analyzed the frequencies of Mycobacterium tuberculosis complex (MTBC) and NTM clinical isolates from 99 200 specimens of patients suspected with pulmonary mycobacterial infection in Taiwan from 2002-2007. A total of 8024 mycobacterial isolates, including 5349 MTBC and 2675 NTM, were obtained from the 99 200 specimens in the study period. The overall mycobacterial isolation rate was 8.09% (8024/99 200), and the overall MTBC and NTM isolation rate was 5.39% (5349/99 200) and 2.7% (2675/99 200), respectively. Notably, the prevalence of NTM isolates among the identified mycobacteria strains was increased 2.6 fold from 2002 (17.54%, 147/838) to 2007 (45.80%, 659/1439). The frequencies of MTBC and NTM isolates showed a reciprocal trend: the NTM isolation rates were steadily increasing while the overall mycobacterial isolation rates remained stable over the study period. Our results suggest that the diagnosis, identification and susceptibility tests for NTM should be standardized and integrated in clinical routines, for providing the information of NTM infection and prescribing clinical treatment in a more precise and efficient way to reduce the increasing NTM in the studied area.
Copyright © 2010 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21239028     DOI: 10.1016/j.trstmh.2010.11.005

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  8 in total

1.  Epidemiology of Nontuberculous Mycobacteria in French Polynesia.

Authors:  Michael Phelippeau; Djaltou Aboubaker Osman; Didier Musso; Michel Drancourt
Journal:  J Clin Microbiol       Date:  2015-12       Impact factor: 5.948

2.  Comparison of the safety and efficacy of a fixed-dose combination regimen and separate formulations for pulmonary tuberculosis treatment.

Authors:  Jiun-Ting Wu; Chien-Tung Chiu; Yu-Feng Wei; Yung-Fa Lai
Journal:  Clinics (Sao Paulo)       Date:  2015-06-01       Impact factor: 2.365

3.  Pulmonary infection and colonization with nontuberculous mycobacteria, Taiwan, 2000-2012.

Authors:  Jung-Yien Chien; Chih-Cheng Lai; Wang-Huei Sheng; Chong-Jen Yu; Po-Ren Hsueh
Journal:  Emerg Infect Dis       Date:  2014-08       Impact factor: 6.883

4.  Mycobacterial Prevalence and Antibiotic Resistance Frequency Trends in Taiwan of Mycobacterial Clinical Isolates From 2002 to 2014.

Authors:  Ming-Yuh Shiau; Ming-Shih Lee; Tian-Lin Huang; Jen-Ning Tsai; Yih-Hsin Chang
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

5.  Epidemiology of and risk factors for extrapulmonary nontuberculous mycobacterial infections in Northeast Thailand.

Authors:  Irin Kham-Ngam; Ploenchan Chetchotisakd; Pimjai Ananta; Prajaub Chaimanee; Phuangphaka Sadee; Wipa Reechaipichitkul; Kiatichai Faksri
Journal:  PeerJ       Date:  2018-08-16       Impact factor: 2.984

6.  Performance of Interferon-Gamma Release Assays in the Diagnosis of Nontuberculous Mycobacterial Diseases-A Retrospective Survey From 2011 to 2019.

Authors:  Chi Yang; Xuejiao Luo; Lin Fan; Wei Sha; Heping Xiao; Haiyan Cui
Journal:  Front Cell Infect Microbiol       Date:  2021-02-18       Impact factor: 5.293

7.  Non-tuberculous mycobacteria and the performance of interferon gamma release assays in Denmark.

Authors:  Thomas Stig Hermansen; Vibeke Østergaard Thomsen; Troels Lillebaek; Pernille Ravn
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

8.  Cutaneous nontuberculous mycobacterial infection in Thailand: A 7-year retrospective review.

Authors:  Phatcharawat Chirasuthat; Korn Triyangkulsri; Suthinee Rutnin; Kumutnart Chanprapaph; Vasanop Vachiramon
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.